MED9 Antikörper (C-Term)
Kurzübersicht für MED9 Antikörper (C-Term) (ABIN2313969)
Target
Alle MED9 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 106-136, C-Term
-
Kreuzreaktivität
- Human, Maus
-
Kreuzreaktivität (Details)
- Calculated cross reactivity: Hu Mo
-
Produktmerkmale
- MED9, CT (MED9, MED25, Mediator of RNA polymerase II transcription subunit 9, Mediator complex subunit 9)
-
Aufreinigung
- Purified by Protein A affinity chromatography.
-
Immunogen
- MED9 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 106-136 amino acids from the C-terminal region of human MED9.
-
Isotyp
- IgG
-
-
anti-Mediator Complex Subunit 9 (MED9) (AA 55-146) antibody
MED9 Reaktivität: Human, Maus, Ratte WB, ELISA, IF, FACS, ICC, IHC Wirt: Kaninchen Polyclonal unconjugated
anti-Mediator Complex Subunit 9 (MED9) (AA 1-146) antibodyMED9 Reaktivität: Human WB, ELISA, IF Wirt: Maus Monoclonal 7F1 unconjugated
anti-Mediator Complex Subunit 9 (MED9) (AA 1-146) antibodyMED9 Reaktivität: Human WB, IF Wirt: Maus Polyclonal unconjugated
anti-Mediator Complex Subunit 9 (MED9) (AA 107-136), (C-Term) antibodyMED9 Reaktivität: Human, Maus WB Wirt: Kaninchen Polyclonal RB38297 unconjugated
-
-
Applikationshinweise
- Optimal working conditions should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- Supplied as a liquid in PBS, pH 7.2, 0.09 % sodium azide.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- -20°C
-
-
- MED9 (Mediator Complex Subunit 9 (MED9))
-
Andere Bezeichnung
- MED9
-
NCBI Accession
- NP_060489
-
UniProt
- Q9NWA0
-
Pathways
- Regulation of Lipid Metabolism by PPARalpha
Target
-
